Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 3212 participants.

Also called NCT04451044

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 3,212 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04451044
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Austria, Canada, Denmark, France, Germany, Israel, Italy, Mexico, Netherlands, Poland, Portugal, South Korea, Spain, Sweden, Switzerland, United Kingdom (from the registry)
Registry status
  • Enrolling by invitation (from the registry)

Technical summary

Registry record NCT04451044. Randomized; double masking; primary purpose treatment. Start 2021-06-17 (actual); primary completion 2026-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting
Acronym
DEFINE GPS
Condition
Ischemic Heart Disease
Intervention (Device)
Philips SyncVision system with Philips pressure wires
Intervention (Procedure)
standard of care angiographically-guided PCI (percutaneous coronary intervention)
Lead sponsor
Philips Clinical & Medical Affairs Global (class: industry)

Record details

Record id
cardio:ct-nct04451044
Content hash
618fd7ff34032e1b4694223e799d52407415594005a1614e6b121cefbad222d7